Reported Jun 20, 2012 · Terminated
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials…
Ben Venue Laboratories Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Ben Venue Laboratories Inc · 300 Northfield Rd · Bedford, OH · 44146
Is this the product you have?
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for
4 of 4 products
| # | Product as published |
|---|---|
| 1 | Bedford Laboratories, Bedford, OH 44146 |
| 2 | Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146 |
| 3 | NDC 55390-160-10 |
| 4 | UPC 3 55390-160-10 1. |
- Lot codes and dates
Lot # 2006500Exp 08/31/12
- Amount recalled
- 6,515 packs
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Ben Venue Laboratories Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.